. . "What the cardiologist should know about type 2 diabetes mellitus and treatment with oral antidiabetic agents"@en . "What the cardiologist should know about type 2 diabetes mellitus and treatment with oral antidiabetic agents"@en . . "N" . . . . "Sou\u010Dek, Miroslav" . . . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetes mellitus 2. typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky" . "metformin; treatment of type 2 diabetes type; cardiovascular complications; diabetes mellitus"@en . "65791" . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetes mellitus 2. typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky"@cs . "1"^^ . "The prevalence of diabetes mellitus second It is currently rising in all developed countries, including the Czech Republic. It also increases the incidence of chronic complications, which include microvascular and macrovascular complications, which are the main cause of death for diabetics. If we want to prevent, we have diabetes mellitus timely diagnose and treat primarily due time. Basic drug is metformin, which should be used in virtually all patients with type 2 diabetes and prediabetem type. Exceptions are gastrointestinal side effects or worsening of renal function. Due to the fact that diabetics are at an increased risk for cardiovascular disease, it is necessary to keep reminding well documented positive cardiovascular effects"@en . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetes mellitus 2. typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky"@cs . "1"^^ . . "RIV/00159816:_____/13:00060838!RIV14-MZ0-00159816" . . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetes mellitus 2. typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky" . . "[6C8ECEFE8DF7]" . "Prevalence diabetes mellitus 2. typu v sou\u010Dasn\u00E9 dob\u011B stoup\u00E1 ve v\u0161ech vysp\u011Bl\u00FDch zem\u00EDch sv\u011Bta v\u010Detn\u011B \u010Cesk\u00E9 republiky. Z\u00E1rove\u0148 se zvy\u0161uje v\u00FDskyt chronick\u00FDch komplikac\u00ED, kam pat\u0159\u00ED mikrovaskul\u00E1rn\u00ED a makrovaskul\u00E1rn\u00ED komplikace, kter\u00E9 jsou u diabetik\u016F hlavn\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED. Pokud jim chceme p\u0159edch\u00E1zet, mus\u00EDme diabetes mellitus v\u010Das diagnostikovat a p\u0159edev\u0161\u00EDm v\u010Das l\u00E9\u010Dit. Z\u00E1kladn\u00EDm l\u00E9kem je metformin, kter\u00FD by m\u011Bl b\u00FDt pod\u00E1v\u00E1n prakticky v\u0161em pacient\u016Fm s prediabetem a diabetem 2. typu. V\u00FDjimkou jsou gastrointestin\u00E1ln\u00ED vedlej\u0161\u00ED \u00FA\u010Dinky nebo zhor\u0161en\u00ED ren\u00E1ln\u00EDch funkc\u00ED. Vzhledem k tomu, \u017Ee diabetici jsou ohro\u017Eeni zv\u00FD\u0161en\u00FDm kardiovaskul\u00E1rn\u00EDm rizikem, je t\u0159eba st\u00E1le p\u0159ipom\u00EDnat dob\u0159e dolo\u017Een\u00E9 pozitivn\u00ED kardiovaskul\u00E1rn\u00ED \u00FA\u010Dinky" . . . "Prevalence diabetes mellitus 2. typu v sou\u010Dasn\u00E9 dob\u011B stoup\u00E1 ve v\u0161ech vysp\u011Bl\u00FDch zem\u00EDch sv\u011Bta v\u010Detn\u011B \u010Cesk\u00E9 republiky. Z\u00E1rove\u0148 se zvy\u0161uje v\u00FDskyt chronick\u00FDch komplikac\u00ED, kam pat\u0159\u00ED mikrovaskul\u00E1rn\u00ED a makrovaskul\u00E1rn\u00ED komplikace, kter\u00E9 jsou u diabetik\u016F hlavn\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED. Pokud jim chceme p\u0159edch\u00E1zet, mus\u00EDme diabetes mellitus v\u010Das diagnostikovat a p\u0159edev\u0161\u00EDm v\u010Das l\u00E9\u010Dit. Z\u00E1kladn\u00EDm l\u00E9kem je metformin, kter\u00FD by m\u011Bl b\u00FDt pod\u00E1v\u00E1n prakticky v\u0161em pacient\u016Fm s prediabetem a diabetem 2. typu. V\u00FDjimkou jsou gastrointestin\u00E1ln\u00ED vedlej\u0161\u00ED \u00FA\u010Dinky nebo zhor\u0161en\u00ED ren\u00E1ln\u00EDch funkc\u00ED. Vzhledem k tomu, \u017Ee diabetici jsou ohro\u017Eeni zv\u00FD\u0161en\u00FDm kardiovaskul\u00E1rn\u00EDm rizikem, je t\u0159eba st\u00E1le p\u0159ipom\u00EDnat dob\u0159e dolo\u017Een\u00E9 pozitivn\u00ED kardiovaskul\u00E1rn\u00ED \u00FA\u010Dinky"@cs . "RIV/00159816:_____/13:00060838" .